Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07195656 · ClinicalTrials.gov registry record · NA

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

A NA study of Overactive Bladder (OAB), sponsored by FemPulse Corporation.

Recruiting
Registry status
NA
Development phase
151
Enrollment target
15
Study locations

NCT07195656 is a NA study of Overactive Bladder (OAB) that is actively recruiting participants, run by FemPulse Corporation. The registered enrollment target is 151 participants, below the 270-participant average among 7 other Overactive Bladder (OAB) trials with a reported enrollment target (44% lower). The trial reports 15 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07195656, a NA study of Overactive Bladder (OAB), is actively recruiting participants, sponsored by FemPulse Corporation.

RECRUITING
Registry status
NA
Development phase
151 participants
Enrollment target
15
Study locations

Study Summary

A study to evaluate the safety and effectiveness of FemPulse System

Conditions Studied

Interventions

  • DEVICE Device Group
  • DRUG Medication Group

Study Locations (15)

California

  • Cedars Sinai - Beverly Hills
  • UCLA - Los Angeles
  • UC Irvine - Orange
  • Stanford - Palo Alto
  • USCD - San Diego

Florida

  • Holy Cross Medical Group - Women's Center - Fort Lauderdale

Illinois

  • Comprehensive Urologic - Barrington

Kentucky

  • University of Louisville - Louisville

Maryland

  • Chesapeake Urology - Owings Mills

Minnesota

  • Minnesota Urology - Woodbury

Nebraska

  • Adult & Pediatric Urology - Omaha

North Carolina

  • Atrium Health - Charlotte

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2025-09-30
Est. Completion 2027-12-31
Phase NA

Sponsor

FemPulse Corporation

6 total trials

What the Registry Record Tells You About NCT07195656

The ClinicalTrials.gov registry entry for NCT07195656 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 270-participant average among 7 other Overactive Bladder (OAB) trials with a reported enrollment target (44% lower). The listed sponsor is FemPulse Corporation, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Overactive Bladder (OAB) appearing as the primary indexed condition, and to 2 interventions - of which Device Group is the first listed.

NCT07195656 reports 15 study locations spanning 11 distinct geographic areas - top geographies include California, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT07195656 about?

NCT07195656 is a clinical study titled "Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)". A study to evaluate the safety and effectiveness of FemPulse System

What is the current status of trial NCT07195656?

This trial is currently recruiting. It is a NA study. The enrollment target is 151 participants. The study started on 2025-09-30. Estimated completion is 2027-12-31.

What conditions does trial NCT07195656 study?

This clinical trial studies the following conditions: Overactive Bladder (OAB).

What interventions are being tested in trial NCT07195656?

The interventions under investigation include: Device Group (DEVICE), Medication Group (DRUG).

Who is sponsoring clinical trial NCT07195656?

This trial is sponsored by FemPulse Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07195656 being conducted?

This trial has 15 study locations across California, Florida, Illinois, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overactive Bladder (OAB)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.